Declining incidence of contralateral breast cancer in the United States from 1975 to 2006
about
Contralateral prophylactic mastectomy: current perspectivesDecision-Making in the Surgical Treatment of Breast Cancer: Factors Influencing Women's Choices for Mastectomy and Breast Conserving SurgeryOncologic safety of conservative mastectomy in the therapeutic settingLobular breast cancer series: imaging.AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.Surveillance Mammography in Older Patients With Breast Cancer-Can We Ever Stop?: A Review.Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.Incidence of Surgical Site Infection Following Mastectomy With and Without Immediate Reconstruction Using Private Insurer Claims Data.Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study.Disparities in contralateral prophylactic mastectomy use among women with early-stage breast cancer.Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study populationEstrogen receptor status in relation to risk of contralateral breast cancer-a population-based cohort study.BRCA1 and BRCA2 Mutation Testing in Young Women With Breast CancerRate of contralateral prophylactic mastectomy is influenced by preoperative MRI recommendations.Contralateral prophylactic mastectomy in the American College of Radiology Imaging Network 6667 trial: effect of breast MR imaging assessments and patient characteristics.Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomyContralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysisInvasive mucinous carcinoma arising in ectopic axillary breast tissue: a case report and literature review.Decision Regret following Treatment for Localized Breast Cancer: Is Regret Stable Over Time?The Manchester guidelines for contralateral risk-reducing mastectomyBreast magnetic resonance imaging (MRI) surveillance in breast cancer survivorsLocal Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.Breast Cancer in the Elderly: Is MRI Helpful?Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.Bilateral Mastectomy versus Breast-Conserving Surgery for Early-Stage Breast Cancer: The Role of Breast Reconstruction.Declining second primary ovarian cancer after first primary breast cancer.Bilateral Mastectomy for Unilateral Breast Cancer: a Perplexing TrendContralateral Prophylactic Mastectomy: Challenging Considerations for the SurgeonClinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situPreoperative Breast Magnetic Resonance Imaging and Contralateral Breast Cancer Occurrence Among Older Women With Breast Cancer.Immediate bilateral nipple-sparing mastectomy and implant-based breast reconstruction.Trends in the use of bilateral mastectomy in England from 2002 to 2011: retrospective analysis of hospital episode statistics.Contralateral prophylactic mastectomy and its impact on quality of lifeOutcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).Association of selected medical conditions with breast cancer risk in Korea.Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.United States trends in the surgical treatment of primary breast cancer.The 2013 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: MRI in breast cancer: where are we now?Magnetic resonance imaging in patients with newly diagnosed breast cancer: a review of the literature.
P2860
Q26744320-DE1CFC50-6C46-4E0C-9BDC-D1C0D385B074Q26749389-20BCCCF8-3F69-4840-9845-0E69099FE899Q26768209-D4E749B8-3C96-46B1-A959-2A99CBB28EF8Q26827192-54DCEEFB-7F38-4287-A77B-634CAC1821D2Q30318240-09BFDD88-4186-46A8-A008-37F66A73224CQ30395721-8E628CE2-1219-44B1-B23C-737D0B81A4AEQ30415050-EEAB7A92-3C83-4D42-A88D-D9401FCA7452Q30964042-54A665D6-25D0-46AD-ADA8-A654CE7271E7Q31118195-1A9472BA-3CDF-4EA6-8333-DD7A9A50ABDFQ33739428-1650DEBC-6A63-4B03-A57B-FF8EC7D9AA99Q33767098-ACDF84DC-21ED-4ED3-982E-90A6CA578E67Q33919320-A987BA17-96EA-4C82-827A-3CD1F909EE7DQ34441602-53B0A026-AC46-4550-9911-803DA2A79F3DQ34513583-A4382E93-F852-4944-9F0A-ACA60A0FC612Q34629071-CF32F605-160B-4E99-8780-67216006AED0Q34678705-91F253A6-9D06-4F15-ABA7-13276789EDA4Q35073191-42A8AA7E-6E6E-420D-AE58-4DFFE1D3B2D2Q35192288-1899156A-C296-4CA3-BB81-20A9E5C057E4Q35208703-15C387F6-4092-467A-B912-435A7E41EE16Q35582455-53FCA035-8FC3-44B1-B43A-C3965A6C8889Q35923270-95E790FB-C439-48F1-AB58-D9FB61443D14Q35998644-B9EC1039-E53B-4197-839E-EFA06F4B3885Q36137506-DF763865-2459-4A48-A1FA-03BA0AE5EEE1Q36264890-6211D437-0BE7-41E2-826C-2C72D4249AE9Q36436637-950D856A-E86B-4D3C-8D0A-2BF7294D241FQ36554681-E8DA1613-232A-4183-8BA1-3AD4F9F00165Q36615095-6357F66C-42E4-4289-9DBC-D4E3C03335E1Q36734744-CFECA987-EA2D-4BA1-A43E-4B1AB9B57EEFQ36812287-AE03F564-3E79-468C-B4AA-2ED552317647Q36820188-00DB7669-9AED-4BEC-A120-85B377E5BDA1Q36914472-345C76C0-A685-4037-8C50-47633D70C255Q36972997-C0982258-9018-4CFF-BA30-BEC15B029763Q37069660-58A711DD-3034-4663-9133-0A489AC8F9AFQ37147521-86848600-500A-4AE2-B8C1-95E0270FF71DQ37267678-C57E5AB1-CD6A-4D06-823B-0C4F485BCFCEQ37385078-87B9A6D0-1D4D-4509-A9D4-8CB96C316A3BQ37669779-AB2A37F2-2255-4AAF-9B0B-54D9F64F484FQ37986554-C1A46FE8-1282-4B23-B707-177E827DF9BDQ38154495-E51D0DF9-C83F-4E1B-980A-98110D45B7F4Q38206146-99E4B18C-F7A4-4392-9675-B3F9AF6011E4
P2860
Declining incidence of contralateral breast cancer in the United States from 1975 to 2006
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Declining incidence of contralateral breast cancer in the United States from 1975 to 2006
@ast
Declining incidence of contralateral breast cancer in the United States from 1975 to 2006
@en
Declining incidence of contralateral breast cancer in the United States from 1975 to 2006
@nl
type
label
Declining incidence of contralateral breast cancer in the United States from 1975 to 2006
@ast
Declining incidence of contralateral breast cancer in the United States from 1975 to 2006
@en
Declining incidence of contralateral breast cancer in the United States from 1975 to 2006
@nl
prefLabel
Declining incidence of contralateral breast cancer in the United States from 1975 to 2006
@ast
Declining incidence of contralateral breast cancer in the United States from 1975 to 2006
@en
Declining incidence of contralateral breast cancer in the United States from 1975 to 2006
@nl
P2093
P2860
P356
P1476
Declining incidence of contralateral breast cancer in the United States from 1975 to 2006
@en
P2093
Amy Berrington de González
Hazel B Nichols
James V Lacey
Philip S Rosenberg
William F Anderson
P2860
P304
P356
10.1200/JCO.2010.32.7395
P407
P577
2011-03-14T00:00:00Z